This guide outlines the SFDA AR license renewal process, the applicable fees, and important timelines to help manufacturers and their representatives stay aligned with Saudi regulatory expectations.
What is an SFDA Authorized Representative License?
An Authorized Representative (AR) is a legal entity based in Saudi Arabia that represents foreign medical device manufacturers before the SFDA. The SFDA AR license is mandatory for registering and marketing medical devices in the Kingdom. Like initial registration, this license must be renewed periodically.
SFDA AR License Renewal Fee for Medical Devices (Official Statement)
“The renewal fee for a Saudi AR license renewal fees for medical devices is typically SAR 10,000 per year. This fee is fixed regardless of the type or number of devices the AR represents. Before applying for an AR license, companies should obtain a registration with the Saudi Food and Drug Authority (SFDA).”
Overview of SFDA AR License Fees for Medical Devices
Annual AR License Renewal Fee: SAR 10,000 (This is a flat rate for all ARs, regardless of product type or volume.)
Other Associated Fees:
Minor changes (e.g., manufacturer name or address): SAR 5,000
Major changes (e.g., change in notified body or legal manufacturer): May trigger full registration fee
Marketing authorization applications: Fees vary depending on the risk class of the medical device (Class A–D)
Prerequisites Before AR License Renewal
Before renewing the AR license, the following must be in place:
Ready to Streamline Your Regulatory Compliance?
Join hundreds of companies who trust OMC Medical for their regulatory needs.
Get expert guidance and ensure compliance across all markets.
When Should You Renew Your AR License in Saudi Arabia?
The SFDA AR license renewal should be initiated well before the license expiry date, typically 3 months in advance. Delays can lead to lapses in compliance, impacting your market access in Saudi Arabia.
Consequences of Missing the Renewal Deadline
Failure to renew the AR license on time can lead to:
Suspension of current device registrations
Delays in new product approvals
Risk of losing legal representation in Saudi Arabia
In some cases, companies may need to restart the entire registration process, including payment of full fees.
Simplify Your Saudi AR License Renewal with OMC Medical
Renewing your SFDA AR license doesn’t have to be stressful. At OMC Medical, we make the process smooth — from reviewing your documents to submitting everything via the GHAD system.
Get the latest OMC updates, resources, and announcements straight to your inbox.
Frequently Asked Questions
The cost of renewing an SFDA Authorized Representative (AR) license can vary depending on the type of license, the validity period, and the regulatory arrangement involved. Since SFDA fee structures can change, it is always best to check the latest applicable fee in the GHAD system before submitting your renewal application.
It is important not to wait until the last minute. SFDA allows renewal applications to be submitted before the license expires, and starting the process early gives you enough time to prepare documents, respond to any requests, and avoid unnecessary compliance gaps.
Yes. The renewal application is generally handled through SFDA's GHAD system. The Authorized Representative can access the relevant licensing service, select the renewal option, update any required information, upload supporting documents, and complete the applicable payment process.
The exact requirements can differ depending on the establishment and its activities. However, applicants may need to provide updated company information, valid Commercial Registration details, representation agreements, and other supporting documents requested by SFDA.
Yes, maintaining a valid Commercial Registration and legally established business status in Saudi Arabia is an important part of meeting the requirements for operating as an Authorized Representative.
Related Blogs
Stay updated with the latest regulatory updates and insights
November 13, 2025
How Regulatory Harmonization Could Speed Up Medical Device Approvals by 2026